ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
VELETRI(에포프로스테놀) 시장 규모는 향후 수년간 강력한 성장이 예상될 예정입니다. 케어 인프라의 개선, 환자 인구 증가에 기인한다고 생각됩니다. 이 기간의 주요 동향으로는 기술의 진보, 제약 기업과 연구 기관의 제휴, 임상 연구의 강력한 파이프라인, 연구 개발 활동 증가, 바이오시밀러나 제네릭 의약품의 출현 등을 들 수 있습니다.
폐동맥 고혈압(PAH)의 유병률 증가는 향후 VELETRI(에포프로스테놀) 시장의 확대를 견인할 것으로 예측됩니다. PAH의 유병률이 증가하는 이유는 진단 기술의 향상, 인구 고령화, 그리고 질병에 대한 인식의 향상 등의 요인들 때문입니다. 미국 심장학회 재단은 PAH로 100만 명당 약 15-30명이 고통을 받고 있다고 보고했습니다.
정맥 질환의 이환율 증가도 VELETRI(에포프로스테놀) 시장을 확장 시킬 것으로 예측됩니다. 정맥 질환은 정맥이 혈류 장애를 경험하여 부기, 통증, 정맥류 및 심부정맥 혈전증과 같은 잠재적 합병증을 유발할 때 발생합니다. 정맥 질환의 유병률 증가는 고령화, 좌식 라이프 스타일, 비만 및 진단 능력 향상과 같은 요인에 의해 영향을받습니다. VELETRI는 폐 혈관에 영향을 미치는 정맥 질환 환자의 운동 능력을 향상시키고 증상을 완화하는 데 사용됩니다. 2025년 1월에 질병통제예방센터(CDC)는 혈전을 유발하는 정맥 혈전색전증(VTE)이 미국에서 매년 최대 90만 명에게 영향을 미치며, 매년 약 6만에서 10만 명이 사망하는 것으로 추정된다고 보고했습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 VELETRI(에포프로스테놀) PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 VELETRI(에포프로스테놀) 시장 : 성장률 분석
세계의 VELETRI(에포프로스테놀) 시장 실적 : 규모와 성장, 2019-2024년
세계의 VELETRI(에포프로스테놀) 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 VELETRI(에포프로스테놀) 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 VELETRI(에포프로스테놀) 시장 : 제품 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
주사제
흡입
세계의 VELETRI(에포프로스테놀) 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
폐동맥고혈압
기타
세계의 VELETRI(에포프로스테놀) 시장 : 유통 채널별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
병원 약국
소매 약국
온라인 약국
세계의 VELETRI(에포프로스테놀) 시장 : 주사제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
정맥내(IV) 주사
피하 주사
세계의 VELETRI(에포프로스테놀) 시장 : 흡입별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
분무기 흡입
건조 분말 흡입
제7장 지역별/국가별 분석
세계의 VELETRI(에포프로스테놀) 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 VELETRI(에포프로스테놀) 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
VELETRI(에포프로스테놀) 시장 : 경쟁 구도
VELETRI(에포프로스테놀) 시장 : 기업 프로파일
Johnson & Johnson
Bayer Pharma AG
Novartis AG
GlaxoSmithKline plc
Gilead Sciences Inc.
제31장 기타 주요 기업 및 혁신 기업
Teva Pharmaceutical Industries Ltd.
Boehringer Ingelheim International GmbH
Sandoz International GmbH
Sun Pharmaceutical Industries Ltd.
Actelion Pharmaceuticals Ltd.
Euroapi SA
United Therapeutics Corporation
Pfizer CentreOne
Sai Life Sciences Limited
Zhejiang Ausun Pharmaceutical Co. Ltd.
Yonsung Fine Chemicals Co. Ltd.
Cayman Pharma Sro
Meitheal Pharmaceuticals Inc.
Smiths Medical
Guangzhou Tosun Pharmaceutical Co. Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 전략
VELETRI(에포프로스테놀) 시장, 2029년 : 새로운 기회를 제공하는 국가
VELETRI(에포프로스테놀) 시장, 2029년 : 새로운 기회를 제공하는 부문
VELETRI(에포프로스테놀) 시장, 2029년 : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
SHW
영문 목차
영문목차
VELETRI (epoprostenol) is a prostacyclin vasodilator used to treat pulmonary arterial hypertension (PAH). It works by relaxing blood vessels and improving blood flow, which helps lower blood pressure in the lungs. Unlike Flolan, VELETRI does not require refrigeration, making it more convenient for continuous infusion. It is administered intravenously to enhance exercise capacity and alleviate symptoms in PAH patients.
The primary types of VELETRI are injectable and inhalation. The injectable form is a prostacyclin (epoprostenol) therapy used to treat pulmonary arterial hypertension (PAH), improving both exercise capacity and symptoms. It has various applications, including PAH and other conditions, and is distributed through a range of channels, such as hospital pharmacies, retail pharmacies, and online pharmacies.
The VELETRI market research report is one of a series of new reports from The Business Research Company that provides VELETRI market statistics, including the VELETRI industry global market size, regional shares, competitors with the VELETRI market share, detailed VELETRI market segments, market trends, and opportunities, and any further data you may need to thrive in the VELETRI industry. This VELETRI market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The VELETRI market size has grown strongly in recent years. It will grow from $1.34 billion in 2024 to $1.45 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth during the historical period can be attributed to several factors, including the rising prevalence of pulmonary arterial hypertension (PAH), greater awareness of the condition, an expanding elderly population, global increases in lifestyle-related health issues, and higher healthcare expenditure.
The VELETRI market size is expected to see strong growth in the next few years. It will grow to $1.95 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth during the forecast period can be attributed to the rising prevalence of venous diseases, increased awareness and early diagnosis, higher spending on chronic diseases, improved healthcare infrastructure, and a growing patient population. Key trends in this period include technological advancements, collaborations between pharmaceutical companies and research institutions, a strong pipeline of clinical research, an increase in R&D activities, and the emergence of biosimilars and generics.
The growing prevalence of pulmonary arterial hypertension (PAH) is expected to drive the expansion of the VELETRI market in the future. PAH is a rare, progressive disease characterized by high blood pressure in the lung arteries, which can lead to heart failure if left untreated. The increasing prevalence of PAH is due to factors such as enhanced diagnostic techniques, an aging population, and heightened awareness of the condition. VELETRI is used to treat PAH by improving exercise capacity and slowing disease progression through vasodilation. For example, in October 2022, the American College of Cardiology Foundation, a US-based nonprofit medical society, reported that PAH affects approximately 15 to 30 people per million. As the prevalence of PAH rises, the demand for VELETRI is expected to grow.
The growing incidence of venous diseases is also expected to drive the VELETRI market forward. Venous diseases occur when veins experience impaired blood flow, resulting in symptoms such as swelling, pain, and potential complications such as varicose veins and deep vein thrombosis. The increasing prevalence of venous diseases is influenced by factors such as an aging population, sedentary lifestyles, obesity, and better diagnostic capabilities. VELETRI is used to improve exercise capacity and alleviate symptoms in patients with venous diseases affecting the pulmonary vasculature. For instance, in January 2025, the Centers for Disease Control and Prevention (CDC) reported that venous thromboembolism (VTE), which causes blood clots, impacts up to 900,000 people annually in the United States, with an estimated 60,000 to 100,000 deaths linked to VTE each year. As venous diseases continue to rise, the VELETRI market will likely grow.
Rising healthcare spending is also expected to fuel the demand for VELETRI. The increase in healthcare expenditure is driven by factors such as aging populations, advanced medical technologies, a rise in chronic diseases, and higher drug and treatment costs. The growth in healthcare spending ensures the affordability, accessibility, and continued research of VELETRI, making it available for PAH patients who require long-term intravenous therapy. For instance, in November 2024, Eurostat, a Luxembourg-based governmental organization, reported that healthcare expenditure in Europe rose from $1.69 trillion in 2021 to $1.75 trillion in 2022, marking a 3.6% increase. This growing healthcare investment is expected to further drive the expansion of the VELETRI market.
Major players in the VELETRI market are Johnson & Johnson, Bayer Pharma AG, Novartis AG, GlaxoSmithKline plc, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Actelion Pharmaceuticals Ltd., Euroapi S.A., United Therapeutics Corporation, Pfizer CentreOne, Sai Life Sciences Limited, Zhejiang Ausun Pharmaceutical Co. Ltd., Yonsung Fine Chemicals Co. Ltd., Cayman Pharma S.r.o., Meitheal Pharmaceuticals Inc., Smiths Medical, and Guangzhou Tosun Pharmaceutical Co. Ltd.
North America was the largest region in the VELETRI market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in VELETRI report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the VELETRI market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The VELETRI market consists of sales of injections, biosimilars, infusion systems, and related equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
VELETRI Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on veletri market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for veletri ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veletri market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Injectable; Inhalation
2) By Application: Pulmonary Arterial Hypertension; Other Applications
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Injectable: Intravenous (IV) Injection; Subcutaneous (SC) Injection
2) By Inhalation: Nebulized Inhalation; Dry Powder Inhalation
Companies Mentioned: Johnson & Johnson; Bayer Pharma AG; Novartis AG; GlaxoSmithKline plc; Gilead Sciences Inc.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. VELETRI Market Characteristics
3. VELETRI Market Trends And Strategies
4. VELETRI Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global VELETRI Growth Analysis And Strategic Analysis Framework
5.1. Global VELETRI PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global VELETRI Market Growth Rate Analysis
5.4. Global VELETRI Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global VELETRI Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global VELETRI Total Addressable Market (TAM)
6. VELETRI Market Segmentation
6.1. Global VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectable
Inhalation
6.2. Global VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pulmonary Arterial Hypertension
Other Applications
6.3. Global VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.4. Global VELETRI Market, Sub-Segmentation Of Injectable, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous (IV) Injection
Subcutaneous (SC) Injection
6.5. Global VELETRI Market, Sub-Segmentation Of Inhalation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nebulized Inhalation
Dry Powder Inhalation
7. VELETRI Market Regional And Country Analysis
7.1. Global VELETRI Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global VELETRI Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific VELETRI Market
8.1. Asia-Pacific VELETRI Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China VELETRI Market
9.1. China VELETRI Market Overview
9.2. China VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India VELETRI Market
10.1. India VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan VELETRI Market
11.1. Japan VELETRI Market Overview
11.2. Japan VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia VELETRI Market
12.1. Australia VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia VELETRI Market
13.1. Indonesia VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea VELETRI Market
14.1. South Korea VELETRI Market Overview
14.2. South Korea VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe VELETRI Market
15.1. Western Europe VELETRI Market Overview
15.2. Western Europe VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK VELETRI Market
16.1. UK VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany VELETRI Market
17.1. Germany VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France VELETRI Market
18.1. France VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy VELETRI Market
19.1. Italy VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain VELETRI Market
20.1. Spain VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe VELETRI Market
21.1. Eastern Europe VELETRI Market Overview
21.2. Eastern Europe VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia VELETRI Market
22.1. Russia VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America VELETRI Market
23.1. North America VELETRI Market Overview
23.2. North America VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA VELETRI Market
24.1. USA VELETRI Market Overview
24.2. USA VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada VELETRI Market
25.1. Canada VELETRI Market Overview
25.2. Canada VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America VELETRI Market
26.1. South America VELETRI Market Overview
26.2. South America VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil VELETRI Market
27.1. Brazil VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East VELETRI Market
28.1. Middle East VELETRI Market Overview
28.2. Middle East VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa VELETRI Market
29.1. Africa VELETRI Market Overview
29.2. Africa VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. VELETRI Market Competitive Landscape And Company Profiles
30.1. VELETRI Market Competitive Landscape
30.2. VELETRI Market Company Profiles
30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Bayer Pharma AG Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
31. VELETRI Market Other Major And Innovative Companies
31.1. Teva Pharmaceutical Industries Ltd.
31.2. Boehringer Ingelheim International GmbH
31.3. Sandoz International GmbH
31.4. Sun Pharmaceutical Industries Ltd.
31.5. Actelion Pharmaceuticals Ltd.
31.6. Euroapi S.A.
31.7. United Therapeutics Corporation
31.8. Pfizer CentreOne
31.9. Sai Life Sciences Limited
31.10. Zhejiang Ausun Pharmaceutical Co. Ltd.
31.11. Yonsung Fine Chemicals Co. Ltd.
31.12. Cayman Pharma S.r.o.
31.13. Meitheal Pharmaceuticals Inc.
31.14. Smiths Medical
31.15. Guangzhou Tosun Pharmaceutical Co. Ltd.
32. Global VELETRI Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The VELETRI Market
34. Recent Developments In The VELETRI Market
35. VELETRI Market High Potential Countries, Segments and Strategies
35.1 VELETRI Market In 2029 - Countries Offering Most New Opportunities
35.2 VELETRI Market In 2029 - Segments Offering Most New Opportunities
